Drug firm GlaxoSmithKline Pharmaceuticals today posted a nearly 4 per cent increase in its net profit to Rs 128.9 crore in the quarter-ended June 30, 2010, over the same period last year.
The company had a net profit of Rs 124.35 crore in the corresponding period last year, GlaxoSmithKline Pharmaceuticals said in a filing to the Bombay Stock Exchange.
During the quarter, net sales of the company stood at Rs 497.93 crore, a nine per cent increase from Rs 457.41 crore
registered in the same period previous year.
"Sales of pharmaceuticals were adversely impacted on account of constraints on vaccine supply during the quarter,"the company said.
In the six-months ended June 30, 2010, the company's net profit stood at Rs 290.18 crore, as against Rs 267.62 crore recorded in the corresponding period last year.
During the period, GlaxoSmithKline Pharmaceuticals had a net sales of Rs 1,039.03 crore, as against Rs 914.56 crore posted in the year ago-period.
